Abich Financial Wealth Management LLC Verve Therapeutics, Inc. Transaction History
Abich Financial Wealth Management LLC
- $147 Billion
- Q2 2024
A detailed history of Abich Financial Wealth Management LLC transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Abich Financial Wealth Management LLC holds 284 shares of VERV stock, worth $1,420. This represents 0.0% of its overall portfolio holdings.
Number of Shares
284
Previous 14
1928.57%
Holding current value
$1,420
Previous $186,000
645.16%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VERV
# of Institutions
174Shares Held
74.8MCall Options Held
115KPut Options Held
144K-
Alphabet Inc. Mountain View, CA12.3MShares$61.7 Million3.79% of portfolio
-
Black Rock Inc. New York, NY6.62MShares$33.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$26.3 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.53MShares$22.6 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.87MShares$19.4 Million0.01% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $300M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...